Oxidative Stress and Dermal Toxicity of Iron Oxide Nanoparticles In Vitro
暂无分享,去创建一个
Bengt Fadeel | Vincent Castranova | Valerian E. Kagan | Anna A. Shvedova | Jim E. Riviere | Nancy Monteiro-Riviere | V. Castranova | B. Fadeel | A. Uheida | V. Kagan | N. Monteiro-Riviere | A. Shvedova | E. Kisin | J. Riviere | A. Murray | A. Inman | S. Young | Shih-Houng Young | Ashley R. Murray | A. Tkach | M. Muhammed | T. Burks | M. Waltz | Elena Kisin | Terrance Burks | Abdusalam Uheida | Mamoun Muhammed | Alfred Inman | Alexey Tkach | Micah Waltz
[1] Devi Akella,et al. Theory to Practice: Practice to Theory , 2013 .
[2] R Weissleder,et al. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. , 2000, Radiology.
[3] R. Weissleder,et al. [Development and experimental use of receptor-specific MR contrast media]. , 1996, Der Radiologe.
[4] V. Dixit,et al. Keratinocytes as initiators of inflammation , 1991, The Lancet.
[5] J. Bacri,et al. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. , 2003, Biomaterials.
[6] R. Williams,et al. Nanotechnology Research Directions: IWGN Workshop Report , 2000 .
[7] G. Buettner,et al. ULTRAVIOLET LIGHT‐INDUCED FREE RADICAL FORMATION IN SKIN: AN ELECTRON PARAMAGNETIC RESONANCE STUDY , 1994, Photochemistry and photobiology.
[8] Philippe Robert,et al. Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.
[9] J. Lee,et al. Interleukin-8 production is regulated by protein kinase C in human keratinocytes. , 1994, The Journal of investigative dermatology.
[10] N. Colburn,et al. The role of AP-1, NF-κB and ROS/NOS in skin carcinogenesis: The JB6 model is predictive , 2004, Molecular and Cellular Biochemistry.
[11] P. Jacobs,et al. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.
[12] Freya Q. Schafer,et al. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. , 2001, Free radical biology & medicine.
[13] W. Leonard,et al. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[14] C. Cross,et al. Oxygen-derived species: their relation to human disease and environmental stress. , 1994, Environmental health perspectives.
[15] B. Nickoloff,et al. The cytokine network in psoriasis. , 1991, Archives of dermatology.
[16] Jeremy N Skepper,et al. Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro. , 2007, Biomaterials.
[17] J. Haddad. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. , 2002, Cellular signalling.
[18] S. Margel,et al. Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles. , 2010, Biomaterials.
[19] P. Borm,et al. Mechanisms and mediators in coal dust induced toxicity: a review. , 1999, The Annals of occupational hygiene.
[20] V. Castranova,et al. Redox cycling of phenol induces oxidative stress in human epidermal keratinocytes. , 2000, The Journal of investigative dermatology.
[21] J. Carter,et al. Cytokines and particle-induced inflammatory cell recruitment. , 1997, Environmental health perspectives.
[22] Hon-Man Liu,et al. Macrophage physiological function after superparamagnetic iron oxide labeling , 2008, NMR in biomedicine.
[23] P. Bunn,et al. Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer , 1993 .
[24] Jin-Sil Choi,et al. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. , 2005, Journal of the American Chemical Society.
[25] P. Babinec,et al. Selective treatment of neoplastic cells using ferritin-mediated electromagnetic hyperthermia. , 2000, Medical hypotheses.
[26] Peter van Gelderen,et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells , 2001, Nature Biotechnology.
[27] R. Weissleder,et al. Cellular Uptake and Trafficking of a Prototypical Magnetic Iron Oxide Label In Vitro , 1995, Investigative radiology.
[28] Abraham Nyska,et al. Invited Review: Oxidation of Biological Systems: Oxidative Stress Phenomena, Antioxidants, Redox Reactions, and Methods for Their Quantification , 2002, Toxicologic pathology.
[29] Anna Moore,et al. In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.
[30] P. Cerutti. Response modification in carcinogenesis. , 1989, Environmental health perspectives.
[31] N. Colburn,et al. Tumour promoter induces anchorage independence irreversibly , 1979, Nature.
[32] J. Haddad,et al. Glutathione depletion is associated with augmenting a proinflammatory signal: evidence for an antioxidant/pro-oxidant mechanism regulating cytokines in the alveolar epithelium. , 2000, Cytokines, cellular & molecular therapy.
[33] H. Pahl,et al. Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. , 1994, Chemico-biological interactions.
[34] C. Wilkinson,et al. Nanotechniques and approaches in biotechnology , 2001 .
[35] P L Shepherd,et al. Theory to practice: the elusive marriage. , 1983 .
[36] Samuel A Wickline,et al. Targeted contrast agents for magnetic resonance imaging and ultrasound. , 2005, Current opinion in biotechnology.
[37] John Calvin Reed,et al. Activation of CPP32 during apoptosis of neurons and astrocytes , 1997, Journal of neuroscience research.
[38] R. Weissleder,et al. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.
[39] Ralph Weissleder,et al. Long-circulating iron oxides for MR imaging , 1995 .
[40] A. Curtis,et al. Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. , 2004, Biomaterials.
[41] J. Dahle,et al. Pigmented melanocytes are protected against ultraviolet-A-induced membrane damage. , 2003, The Journal of investigative dermatology.
[42] V. Hudson. Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation. , 2001, Free radical biology & medicine.
[43] A Curtis,et al. Nantotechniques and approaches in biotechnology. , 2001, Trends in biotechnology.
[44] P. Baeuerle,et al. A role for oxygen radicals as second messengers. , 1991, Trends in cell biology.
[45] J. Haddad. Science review: Redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for nuclear factor-κB , 2002, Critical care.
[46] B. Wallaert,et al. Thiol regulation of the production of TNF-alpha, IL-6 and IL-8 by human alveolar macrophages. , 1999, The European respiratory journal.
[47] A. Papavassiliou,et al. Determining the effect of inducible protein phosphorylation on the DNA-binding activity of transcription factors. , 1992, Analytical biochemistry.
[48] Tony Hunter,et al. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity , 1991, Cell.
[49] E. Corsini,et al. Cytokines and irritant contact dermatitis. , 1998, Toxicology letters.
[50] H. Black. POTENTIAL INVOLVEMENT OF FREE RADICAL REACTIONS IN ULTRAVIOLET LIGHT‐MEDIATED CUTANEOUS DAMAGE * , 1987, Photochemistry and photobiology.
[51] J. Fuchs,et al. Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation. , 1998, Free radical biology & medicine.
[52] R Weissleder,et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.
[53] B. V. Beers,et al. Les oxydes de fer comme agents de contraste en IRM hépatique. , 1995 .
[54] A. Kligman,et al. The nature of photoaging: its prevention and repair. , 1986, Photo-dermatology.
[55] P Wust,et al. Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro. , 1996, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[56] É. Duguet,et al. Magnetic nanoparticle design for medical diagnosis and therapy , 2004 .
[57] A. Curtis,et al. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. , 2003, Biomaterials.
[58] N. Colburn,et al. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells. , 1982, Cancer research.
[59] Packer,et al. Topical application of α‐tocopherol modulates the antioxidant network and diminishes ultraviolet‐induced oxidative damage in murine skin , 1998, The British journal of dermatology.
[60] F. Nachbar,et al. The role of vitamin E in normal and damaged skin , 2004, Journal of Molecular Medicine.
[61] M. Petroff,et al. Mechanisms of cytokine-induced death of cultured bovine luteal cells. , 2001, Reproduction.
[62] M. Pathak,et al. Skin photosensitizing agents and the role of reactive oxygen species in photoaging. , 1992, Journal of photochemistry and photobiology. B, Biology.
[63] P. Reimer,et al. Entwicklung und experimenteller Einsatz von rezeptorspezifischen MR-Kontrastmitteln , 1996, Der Radiologe.
[64] A. Churg,et al. Mechanisms in the pathogenesis of asbestosis and silicosis. , 1998, American journal of respiratory and critical care medicine.
[65] H. Sies,et al. Glutathione and its role in cellular functions. , 1999, Free radical biology & medicine.
[66] I. Fridovich,et al. Free radicals in cutaneous biology. , 1994, The Journal of investigative dermatology.
[67] B. Rutt,et al. Enhanced cell uptake of superparamagnetic iron oxide nanoparticles functionalized with dendritic guanidines. , 2008, Bioconjugate chemistry.
[68] A. Gröne. Keratinocytes and cytokines. , 2002, Veterinary immunology and immunopathology.
[69] Ernst J. Rummeny,et al. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro , 2004, European Radiology.
[70] T. Curran,et al. Encounters with Fos and Jun on the road to AP-1. , 1990, Seminars in cancer biology.
[71] N. Monteiro-Riviere,et al. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. , 2009, Toxicology and applied pharmacology.
[72] Ming Zhao,et al. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent , 2001, Nature Medicine.
[73] Ze'ev Ronai,et al. Role of redox potential and reactive oxygen species in stress signaling , 1999, Oncogene.
[74] H. Hamadeh,et al. Oxidative stress and its role in skin disease. , 2002, Antioxidants & redox signaling.
[75] I. Lucet,et al. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. , 1996, Journal of microencapsulation.
[76] Jinwoo Cheon,et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. , 2005, Journal of the American Chemical Society.
[77] Martin Bendszus,et al. Cytokine profile of iron-laden macrophages: Implications for cellular magnetic resonance imaging , 2006, Journal of Neuroimmunology.
[78] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[79] A. Curtis,et al. Surface modified superparamagnetic nanoparticles for drug delivery: Interaction studies with human fibroblasts in culture , 2004, Journal of materials science. Materials in medicine.
[80] P. Baeuerle,et al. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.
[81] R. Weissleder,et al. Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages , 1997, Journal of magnetic resonance imaging : JMRI.
[82] Conroy Sun,et al. Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. , 2008, Small.